All Posts: cancer research
-
Immunotherapy Combo Halts Rare, Stage 4 Sarcoma in Teen
NUTLEY, NJ (October 14, 2020) — A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment had a “rapid and complete response” to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center […]
Category: News Release
-
BellRinger Bike Ride Announcement Concludes ‘Five Days with Lombardi’
(October 9, 2020) — As part of the celebration of its 50th anniversary during the week of Oct. 5-9, Georgetown Lombardi rolled out plans to hold the inaugural BellRinger Bike Ride in September 2021. “BellRinger will be a cycling event that brings together dedicated individuals and teams focused on ending cancer,” said Louis Weiner, MD, […]
Category: Lombardi Stories
-
FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research
(September 14, 2020) — Julie Shanholtz was having an uneventful summer in 2017 working full time with the same employer she’d had for the past 30 years when she developed an “odd cough” that quickly became severe, but no other symptoms. “I had always been very active and healthy — and didn’t smoke,” the 54-year-old […]
Category: Lombardi Stories
-
First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight
(July 31, 2020) — In the field of breast screening, 3D imaging, or tomosynthesis mammography, has become the go-to screening modality over conventional digital mammography in recent years. But does 3D screening actually improve detection of — and survival from — life-threatening breast cancers, or does conventional mammography perform just as well at a lower […]
Category: Lombardi Stories
-
Georgetown Lombardi Launches COVID-19 Antibody Study in People with Cancer
WASHINGTON (April 29, 2020) — Georgetown Lombardi Comprehensive Cancer Center, in collaboration with MedStar Georgetown University Hospital, has begun a study to test for specific virus antibodies in people with cancer, who are vulnerable to COVID-19. The FDA, has approved (under an emergency use authorization) only a few tests produced commercially to detect antibodies against […]
Category: News Release
-
Georgetown Breast Cancer Researcher Inducted as AAAS Fellow
(February 15, 2020) — For a career aimed at decoding the biggest challenge in treating the most common cancer in women, the Council of the American Association for the Advancement of Science (AAAS) inducted Georgetown’s Robert Clarke, PhD, DSc, as an AAAS Fellow. The Council elects Fellows annually to honor scientists whose “efforts on behalf […]
Category: Lombardi Stories
-
Hyundai Hands on Hope Contest Again to Raise Money for Pediatric Cancer Research at Georgetown Lombardi
(January 24, 2020) — Georgetown Lombardi has teamed up once again with the Washington Area Hyundai Dealers at the Washington Auto Show to help raise money for pediatric cancer research through the Hyundai Hands On Hope Contest. The contest requires participants to remain in constant contact with a Hyundai vehicle over two days (with a […]
Category: Lombardi Stories
-
Gut Bacteria May Be One Culprit for Increase of Colorectal Cancer in Younger People
SAN FRANCISCO (January 21, 2020) — A bacteria typically linked to periodontal disease, Fusobacterium nucleatum (F. nuc), could play an important role in the rising incidence of colorectal cancer in people under the age of 45. Another type of bacteria, Moraxella osloensis, has been found in colorectal cancer tumors at a nearly four-fold higher rate […]
Category: News Release
-
New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
WASHINGTON (January 21, 2020) — Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance. The study by Georgetown Lombardi Comprehensive Cancer Center researchers appeared […]
Category: News Release
-
Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice
WASHINGTON (December 30, 2019) — Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast […]
Category: News Release